Not Yet Recruiting NA INTERVENTIONAL 2-arm
NCT07466511
Effect of Bifidobacterium Breve Supplementation on the Onset and Progression of Idiopathic Scoliosis
Effect of Bifidobacterium Breve Supplementation on the Onset and Progression of Idiopathic Scoliosis: A Prospective, Single-Blind, Randomized Controlled Trial
Sponsor: Second Affiliated Hospital of Wenzhou Medical University
Conditions
Idiopathic Scoliosis
Interventions
Bifidobacterium breve Lifestyle Education
Updated 1 time since 2026 Last updated: Mar 9, 2026 Started: Jan 1, 2027 Primary completion: Oct 1, 2030 Completion: Dec 31, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This NA trial investigates Idiopathic Scoliosis and is currently actively recruiting participants. Second Affiliated Hospital of Wenzhou Medical University leads this study, which shows 1 recorded version since 2027 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Not Yet Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Second Affiliated Hospital of Wenzhou Medical University
Data source: Second Affiliated Hospital of Wenzhou Medical University
For direct contact, visit the study record on ClinicalTrials.gov .